Clark Estates Inc’s Quest Diagnostics DGX Stock Holding History

Clark Estates Inc’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-40,500	Closed	-$2.46M	–	120
2014 Q3	$2.46M	Hold	40,500	–	–	0.39%	51
2014 Q2	$2.38M	Hold	40,500	–	–	0.34%	61
2014 Q1	$2.35M	Buy	40,500 +11,500	+40%	+$616K	0.35%	54
2013 Q4	$1.55M	Sell	29,000 -249,000	-90%	-$14.8M	0.22%	82
2013 Q3	$17.2M	Buy	278,000 +30,700	+12%	+$1.84M	2.6%	9
2013 Q2	$15M	Buy	+247,300	New	+$14.7M	2.59%	11

Other funds holding DGX

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Clark Estates Inc's DGX Position: Q4 2014 in Review

Clark Estates Inc sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 40,500 shares — an estimated $2.46M sold.

Clark Estates Inc first reported a position in DGX in Q2 2013 and held it in 6 quarters. The position peaked at $17.2M in Q3 2013. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

Clark Estates Inc reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
Clark Estates Inc sold 40,500 Quest Diagnostics shares in Q4 2014, an estimated $2.46M.
Clark Estates Inc first reported a position in Quest Diagnostics in Q2 2013 and held it in 6 quarters.
Clark Estates Inc's Quest Diagnostics position peaked at $17.2M in Q3 2013.
517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Clark Estates Inc's 13F filing for Q4 2014, filed 11 Feb 2015.